Therapeutic efficacy and safety of one-week intermittent therapy with itraconazole for onychomycosis in a Chinese patient population

Dermatology

Volumn 199, Issue 1, 1999, Pages 47-49

  Wang, D L ^a   Wang, A P ^a   Li, R Y ^a   Wang, Rose ^b,c  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b Xi'an Janssen Pharmaceutica Ltd   (China)

^c Ocean Building ^*  (China)

Author keywords

Antifungal agent; Intermittent therapy; Itraconazole; Onychomycosis

Indexed keywords

ANTIFUNGAL AGENT; ITRACONAZOLE;

ADULT; AGED; ANOREXIA; ARTICLE; CHINESE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; EDEMA; FEMALE; FINGER NAIL; GASTROINTESTINAL SYMPTOM; HUMAN; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALAISE; MALE; MULTICENTER STUDY; NAUSEA; ONYCHOMYCOSIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TOE; XEROSTOMIA;

EID: 0032785684     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000018177     Document Type: Article

References (9)

1. Gupta AK, De Doncker P, Scher RK, Haneke E, Daniel CR III, André J, Baran R: Itraconazole for the treatment of onychomycosis. Int J Dermatol 1998;37:303-308.
2. Cauwenbergh G, Degreef H, Heykants J, Woestenborghs R, Van Rooy P, Haeverans K: Pharmacokinetic profile of orally administered itraconazole in human skin. J Am Acad Dermatol 1988;18:263-268.
3. Willemsen M, De Doncker P, Willems J, Woestenborghs R, Van de Velde V, Heykants J, Van Cutsem J, Cauwenbergh G, Roseeuw D: Posttreatment itraconazole levels in the nail: New implications for treatment in onychomycosis. J Am Acad Dermatol 1992;26:731-735.
4. Matthieu L, De Doncker P, Cauwenbergh G, Woestenborghs R, van de Velde V, Janssen PAJ, Dockx P: Itraconazole penetrates the nail via the nail matrix and the nail bed - An investigation in onychomycosis. Clin Exp Dermatol 1991;16:374-376.
5. Havu V, Brandt H, Heikkila H, Hollmen A, Oksman R, Rantanen T, Saari S, Stubb S, Turjanmaa K, Piepponen T: A double-blind, randomized study comparing itraconazole pulse therapy with continuous dosing for the treatment of toe-nail onychomycosis. Br J Dermatol 1997;136:230-234.
6. Odom RB. Aly R, Scher RK, Daniel CR III, Elewski BE, Zaias N, DeVillez R, Jacko M, Oleka N, Moskovitz BL: A multicenter, placebo-controlled, double-blind study of intermittent therapy with itraconazole for the treatment of onychomycosis of the fingernail. J Am Acad Dermatol 1997;36:231-235.
7. Yu RY, Gao L: Treatment of fingernail and toenail onychomycosis by itraconazole intermittent pulse therapy: 40 case reports. Chin J Dermatol 1995;28:275-276.
8. Sun QN, Wang JB: Treatment of 40 cases of onychomycosis by itraconazole intermittent pulse therapy. Chin J Dermatol 1996;29:12-14.
9. Van Doorslaer EKA, Tormans G, Gupta AK, Van Rossem K, Eggleston A, Dubois DJ, De Doncker P, Haneke E: Economic evaluation of antifungal agents in the treatment of toenail onychomycosis in Germany. Dermatology 1996;193:239-244.